| 3161 |
177: Mitochondrial dysfunction |
2144: Impaired insulin signaling |
Mar 13, 2024 |
Mar 13, 2024 |
1 AOP
|
| 3164 |
177: Mitochondrial dysfunction |
1917: Altered expression of NRF2 pathway-dependent genes |
Mar 14, 2024 |
Mar 14, 2024 |
1 AOP
|
| 3165 |
177: Mitochondrial dysfunction |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Mar 14, 2024 |
Mar 14, 2024 |
1 AOP
|
| 2193 |
1816: Mitochondrial dysfunction EMPTY |
1817: Apoptotic cell death |
Nov 2, 2020 |
Nov 2, 2020 |
None
|
| 2195 |
1816: Mitochondrial dysfunction EMPTY |
1815: ER stress |
Nov 2, 2020 |
Nov 2, 2020 |
None
|
| 2499 |
1816: Mitochondrial dysfunction EMPTY |
1392: Oxidative Stress |
Oct 26, 2021 |
Oct 26, 2021 |
1 AOP
|
| 2932 |
1816: Mitochondrial dysfunction EMPTY |
2144: Impaired insulin signaling |
May 25, 2023 |
May 25, 2023 |
None
|
| 3043 |
1816: Mitochondrial dysfunction EMPTY |
1585: Proteasomal dysfunction |
Sep 14, 2023 |
Sep 14, 2023 |
None
|
| 1941 |
1547: Mitochondrial Injury |
1546: Increased reactive oxygen species (in the mitochondria) |
Jun 7, 2019 |
Jun 7, 2019 |
None
|
| 1942 |
1547: Mitochondrial Injury |
889: Impaired, Proteostasis |
Jun 7, 2019 |
Jun 7, 2019 |
None
|
| 2715 |
1547: Mitochondrial Injury |
1825: Increase, Cell death |
Jul 25, 2022 |
Jul 25, 2022 |
None
|
| 3049 |
1547: Mitochondrial Injury |
1812: Increase, Cyt c release |
Sep 14, 2023 |
Sep 14, 2023 |
1 AOP
|
| 603 |
598: modulation, sodium channel |
599: prolonged, Depolarization of neuronal membrane |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 802 |
801: modulation, Unknown |
802: Increased, HIF-1 alpha transcription |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2448 |
1912: Motile Cilia Number/Length, Decreased |
1908: CBF, Decreased |
Jul 23, 2021 |
Sep 28, 2021 |
1 AOP
|
| 1563 |
1425: Mu Opioid Receptor Agonism |
1426: Release of G Proteins |
Jun 8, 2017 |
Jun 8, 2017 |
2 AOPs
|
| 2443 |
1909: MCC, Decreased |
1250: Decreased lung function |
Jul 19, 2021 |
Mar 24, 2023 |
3 AOPs
|
| 2445 |
1910: Mucus Viscosity, Increased |
1908: CBF, Decreased |
Jul 19, 2021 |
Aug 2, 2021 |
None
|
| 2446 |
1910: Mucus Viscosity, Increased |
1909: MCC, Decreased |
Jul 19, 2021 |
Aug 2, 2021 |
None
|
| 33 |
27: N/A, Androgen receptor, Antagonism |
286: Altered, Transcription of genes by the AR |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 35 |
27: N/A, Androgen receptor, Antagonism |
310: Alteration, Wnt pathway |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 757 |
764: N/A, Ataxia, paralysis, or hyperactivity |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 88 |
75: N/A, Covalent binding to protein, possibly lysine residue |
151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways |
Nov 29, 2016 |
Sep 24, 2020 |
None
|
| 1700 |
75: N/A, Covalent binding to protein, possibly lysine residue |
398: Activation, Dendritic Cells |
Dec 7, 2017 |
Sep 24, 2020 |
None
|
| 136 |
119: N/A, Gap |
49: Reduction, Ca and HCO3 transport to shell gland |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|